On Friday, the U.S. Centers for Disease Control and Prevention (CDC) was forced to admit publicly that zero nicotine-based vapes can be linked to the “vaping-related” lung disorder of this past summer. 

Public health experts like Dr. Michael Siegel of Boston University have been very critical of the agency’s mishandling of the associated messaging campaign, calling its public warnings to avoid all vapor products “intentionally vague.”

The truth always comes out eventually, Siegel foretold, and the real culprit– THC-enhanced cartridges – should have been made crystal clear in the early days of the mysterious outbreak to avoid an escalating death toll. Siegel was right on both counts.  Today, each of the 50 states is now reporting at least one patient with e-cigarette, or vaping, product use–associated lung injury (EVALI), and the CDC has confirmed at least 25 EVALI-related deaths across 25 states

DANK VAPES IS LINKED TO OVER HALF OF ALL EVALI DIAGNOSES

According to the recent CDC press release, approximately 56 percent of all patients in the country suffering from the EVALI lung disorders reported using a Dank Vapes product within the prior three months of being diagnosed.   The TKO, Smart Cart, and Rove brands were also popular products liked to the respiratory scandal coming in at 15 percent, 13 percent, and 12 percent respectively.  In total, over 150 THC-containing vapor products were identified in the CDC probe, but not a single FDA-regulated nicotine-based e-cig made the list.

“Nationally, Dank Vapes were the most commonly reported THC-containing product by hospitalized EVALI patients, but a wide variety of products were reported, with regional differences. Data suggest the outbreak might have peaked in mid-September.”

Read full article here.

Matt Rowland – VAPES – December 10, 2019.

Want More Investigative Content?

4 COMMENTS

  1. This is an article attempting to clarify information, but it uses a headline that could easily be interpreted as “0mg Nicotine Vapes Linked to Illness”

LEAVE A REPLY

Please enter your comment!
Please enter your name here